#News for #Media and #Investors . We have just released our Trading Update announcing a strong start to 2024, with continued momentum across all businesses and reiterating our full year guidance.
For more, see: hikma.com/news/hikma-has…

At #Hikma , our purpose is to put better health, within reach, every day. We couldn’t do that without our people. Today we salute Shirley Stack, a Group Leader in Inspection & Packaging at our #CherryHill , N.J., facility, for an amazing 50 years of service

#Investors and #Media . We've published our #2023AnnualReport . We made significant progress last year, launching new products, growing across the Group as we continue to make high-quality medicines more accessible to the patients in need.
2023 Annual Report
hikma.com/investors/2023…

Hikma will be attending the American Academy of Pain Medicine (AAPM) 2024 Annual Meeting from March 7-10 in Scottsdale, AZ. Stop by our booth to meet the team and learn more about how we can help you meet the needs of your providers and patients. #AAPM2024

#RareDiseaseDay serves as a powerful reminder of the millions living with rare diseases. At #Hikma , we're committed to #advancinghealth and #wellbeing and enabling access to treatments options to improve patients’ lives.
#ShareyourCOLOURS
Learn more at hikma.com

#News for #Investors . Riad Mishlawi, Hikma’s CEO, will be meeting with investors at the #UBS European Healthcare Conference in London on Tuesday 27 February. #Generics #Pharmaceuticals #Hikma

Learn more about Hikma hikma.com

#News for #Investors and #Media
#DYK Hikma is now the 2nd largest pharmaceutical company in MENA?
We’re proud to celebrate over #45years of enabling patients’ access to high-quality essential #medicines and healthcare solutions to millions of #patients .
brnw.ch/21wHinu

#هل_تعلم بأن الحكمة أصبحت في المرتبة الثانية كأكبر شركة أدوية في الشرق الأوسط وشمال أفريقيا؟
نفخر بالاحتفال بأكثر من 45 عامًا من تعزيز وصول #الأدوية الأساسية عالية الجودة وحلول الرعاية الصحية للملايين من الناس حول العالم.
اعرف المزيد عن الحكمة: hikma.com

We were honored to host ONDCP Director Rahul Gupta at our Columbus, Ohio manufacturing site for a visit and dialogue on the US opioid epidemic, and how industry, government, and others can work together to meet the urgent needs of patients and communities. brnw.ch/21wHfQb

#News for #Media and #Investors .
Check our 2023 Full Year Results
hikma.com/investors/

#News for #Media and #Investors .

Watch Dr Bill Larkins, President Injectables discuss the solid performance of our global Injectables business, supported by good growth in all three of our geographies.
youtu.be/Ad-b0Zu4ZFk

#News for #Media and #Investors .

Watch Mazen Darwazah, Executive Vice Chairman and President of MENA discuss the Branded segment’s stand-out performance in 2023, which is now the second largest pharmaceutical company in MENA by sales.

youtu.be/8zFfgX2003Q

#News for #Media and #Investors .

Watch Brian Hoffmann, President Generics discuss the record performance of our Generics business in 2023. With double-digit revenue and core operating profit growth, this was an outstanding year for Generics.
youtu.be/I6dSzbEu-dM

#News for #Media and #Investors .

Watch our CFO, Khalid Nabilsi discuss our strong 2023 performance, with good growth in all three of our businesses.

youtu.be/vpS3pTAst8U

#News for #Media and #Investors . #Hikma announces its 2023 Full Year Results. Watch Riad Mishlawi, CEO
youtu.be/GAGIozXAMdA

Hikma Generics President, Brian Hoffmann, recently joined leaders at Access! 2024 to discuss vital policy and regulatory priorities for #generics and #biosimilars companies in the #US today.
#Hikma #Access2024

#News for #Investors and #Media
#Hikma is proud to announce its exclusive partnership with AFT Pharmaceuticals introducing a patented #pain reliever to #KSA #Jordan and #Iraq , expanding our commitment to quality healthcare in #MENA .

تفتخر #الحكمة بالإعلان عن شراكتها الحصرية مع شركة AFT Pharmaceuticals لتوفير #مسكن للآلام حاصل على براءة اختراع، في #السعودية و #الأردن و #العراق ، مما يرسخ التزامنا بالرعاية الصحية عالية الجودة في منطقة الشرق الأوسط وشمال أفريقيا.

We are pleased to have today launched an important new branded medicine for adult patients in the US. View our press release to learn more about how this milestone is helping advance our mission to bring better health, within reach, every day. brnw.ch/21wGH8Q #HikmaCares

#News for #Analysts #Investors and #Media . #Hikma will announce its preliminary financial results for the year ended 31 December 2023 on Thursday 22 February 2024. Hikma will hold a Q&A call for analysts at 12:00 PM GMT.
brnw.ch/21wGGd9